SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-24-008415
Filing Date
2024-02-16
Accepted
2024-02-16 17:30:35
Documents
2
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1388
2 EXHIBIT 24.1 ef20021901_ex24-1.htm EX-24.1 8105
  Complete submission text file 0001140361-24-008415.txt   11250
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141
Business Address
Cicala Peter (Reporting) CIK: 0002011534 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 24649741